Connecticut Medical Board fines doctor $10,000 in prescription case – Hartford Courant

The state medical examination board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe drugs. controlled substances to a family member.

In addition to the fine, the council also voted unanimously to reprimand the medical license of the physician, Marc D. Legris, and ordered him to take an ethics course and practice in a supervised practice. The prescription does not indicate the name of the doctor Legris contacted.

In a council-approved consent order, Legris chose not to contest the allegations.

Department of Public Health records show that in August 2021, Legris relinquished his own DEA registration and controlled substance designation in Connecticut. DPH began its investigation after a referral from the state Department of Consumer Protection.

The consent order states that Legris prescribed the drugs to a family member on a recurring basis from August 2018 to August 2021. The relative was not a patient of his and he did not keep medical records for the parent, the order said.

In an unrelated case, the board unanimously voted to fine former Hartford allergist Dr. Michael L. Krall $2,000 and reprimand his medical license, according to state records. for prescribing cough medicine with codeine to a family member six times between May 2017 and May 2020.

The relative was not his patient, and Krall did not keep medical records for the family member, pursuant to a council-approved consent order. Krall, who now lives in Boston and no longer practices medicine in Connecticut, chose not to contest the allegations, the order said. Consumer protection had forwarded the file to the DPH.

This story was reported in partnership with the Connecticut Health I-Team (, a nonprofit news organization dedicated to health reporting.

Source link

About Alex S. Crone

Check Also

Top 20 most expensive prescription drugs in 2022

If you thought inflation was high, wait until you hear about rising specialty drug prices. …